{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:29:35Z","timestamp":1792099775526,"version":"4.4.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00726-010-0777-y","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T07:50:25Z","timestamp":1287042625000},"page":"1221-1236","source":"Crossref","is-referenced-by-count":116,"title":["Advanced glycation endproducts and their pathogenic roles in neurological disorders"],"prefix":"10.1007","volume":"42","author":[{"given":"Gerald","family":"M\u00fcnch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Menini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Gugliucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"issue":"1","key":"777_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","volume":"67","author":"N Ahmed","year":"2005","unstructured":"Ahmed N (2005) Advanced glycation endproducts\u2014role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3\u201321","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"777_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbadis.2003.08.002","volume":"1639","author":"N Ahmed","year":"2003","unstructured":"Ahmed N, Battah S, Karachalias N, Babaei-Jadidi R, Horanyi M, Baroti K, Hollan S, Thornalley PJ (2003) Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim Biophys Acta 1639(2):121\u2013132","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"777_CR3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.1207844","volume":"84","author":"A Andersson","year":"2008","unstructured":"Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallstrom E, Lobell A, Brundin L, Lassmann H, Harris RA (2008) Pivotal advance: Hmgb1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 84(5):1248\u20131255","journal-title":"J Leukoc Biol"},{"issue":"7","key":"777_CR4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.braindev.2005.12.004","volume":"28","author":"Y Anzai","year":"2006","unstructured":"Anzai Y, Hayashi M, Fueki N, Kurata K, Ohya T (2006) Protracted juvenile neuronal ceroid lipofuscinosis\u2014an autopsy report and immunohistochemical analysis. Brain Dev 28(7):462\u2013465","journal-title":"Brain Dev"},{"issue":"11","key":"777_CR5","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood.V87.11.4507.bloodjournal87114507","volume":"87","author":"R Arya","year":"1996","unstructured":"Arya R, Lalloz MR, Nicolaides KH, Bellingham AJ, Layton DM (1996) Prenatal diagnosis of triosephosphate isomerase deficiency. Blood 87(11):4507\u20134509","journal-title":"Blood"},{"issue":"3","key":"777_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cyto.2007.11.012","volume":"41","author":"K Berbaum","year":"2008","unstructured":"Berbaum K, Shanmugam K, Stuchbury G, Wiede F, Korner H, M\u00fcnch G (2008) Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine 41(3):198\u2013203","journal-title":"Cytokine"},{"issue":"12","key":"777_CR7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","volume":"114","author":"A Bierhaus","year":"2004","unstructured":"Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundorfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114(12):1741\u20131751","journal-title":"J Clin Invest"},{"issue":"11","key":"777_CR8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00702-008-0126-4","volume":"115","author":"K Bigl","year":"2008","unstructured":"Bigl K, Gaunitz F, Schmitt A, Rothemund S, Schliebs R, M\u00fcnch G, Arendt T (2008) Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm 115(11):1545\u20131556","journal-title":"J Neural Transm"},{"issue":"1","key":"777_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/db07-0838","volume":"57","author":"M Blatnik","year":"2008","unstructured":"Blatnik M, Frizzell N, Thorpe SR, Baynes JW (2008) Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: Formation of s-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress. Diabetes 57(1):41\u201349","journal-title":"Diabetes"},{"issue":"1","key":"777_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2990.1988.tb00864.x","volume":"14","author":"H Braak","year":"1988","unstructured":"Braak H, Braak E (1988) Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol 14(1):39\u201344","journal-title":"Neuropathol Appl Neurobiol"},{"key":"777_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","volume":"46","author":"M Brownlee","year":"1995","unstructured":"Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223\u2013234","journal-title":"Annu Rev Med"},{"issue":"5","key":"777_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.0954-6820.1983.tb03756.x","volume":"213","author":"G Bucht","year":"1983","unstructured":"Bucht G, Adolfsson R, Lithner F, Winblad B (1983) Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 213(5):387\u2013392","journal-title":"Acta Med Scand"},{"issue":"7","key":"777_CR13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1464-5491.1993.tb00131.x","volume":"10","author":"NE Cameron","year":"1993","unstructured":"Cameron NE, Cotter MA (1993) Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabet Med 10(7):593\u2013605","journal-title":"Diabet Med"},{"issue":"1","key":"777_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/138945008783431718","volume":"9","author":"NE Cameron","year":"2008","unstructured":"Cameron NE, Cotter MA (2008) Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa b pathway. Curr Drug Targets 9(1):60\u201367","journal-title":"Curr Drug Targets"},{"issue":"11","key":"777_CR15","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s001250100001","volume":"44","author":"NE Cameron","year":"2001","unstructured":"Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44(11):1973\u20131988","journal-title":"Diabetologia"},{"issue":"9","key":"777_CR16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jms.517","volume":"38","author":"M Carini","year":"2003","unstructured":"Carini M, Aldini G, Beretta G, Arlandini E, Facino RM (2003) Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine\/acrolein adducts by electrospray ionization tandem mass spectrometry. J Mass Spectrom 38(9):996\u20131006","journal-title":"J Mass Spectrom"},{"issue":"2","key":"777_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0891-5849(94)E0134-5","volume":"18","author":"R Carubelli","year":"1995","unstructured":"Carubelli R, Schneider JE Jr, Pye QN, Floyd RA (1995) Cytotoxic effects of autoxidative glycation. Free Radic Biol Med 18(2):265\u2013269","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"777_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(96)00729-9","volume":"737","author":"R Castellani","year":"1996","unstructured":"Castellani R, Smith MA, Richey PL, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737(1\u20132):195\u2013200","journal-title":"Brain Res"},{"issue":"2","key":"777_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0891-5849(01)00570-6","volume":"31","author":"RJ Castellani","year":"2001","unstructured":"Castellani RJ, Harris PL, Sayre LM, Fujii J, Taniguchi N, Vitek MP, Founds H, Atwood CS, Perry G, Smith MA (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 31(2):175\u2013180","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"777_CR20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1534\/genetics.106.063206","volume":"174","author":"AM Celotto","year":"2006","unstructured":"Celotto AM, Frank AC, Seigle JL, Palladino MJ (2006) Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy. Genetics 174(3):1237\u20131246","journal-title":"Genetics"},{"issue":"10","key":"777_CR21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","volume":"198","author":"T Chavakis","year":"2003","unstructured":"Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP (2003) The pattern recognition receptor (rage) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198(10):1507\u20131515","journal-title":"J Exp Med"},{"issue":"5","key":"777_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF03401739","volume":"4","author":"SM Chou","year":"1998","unstructured":"Chou SM, Wang HS, Taniguchi A, Bucala R (1998) Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol Med 4(5):324\u2013332","journal-title":"Mol Med"},{"issue":"2","key":"777_CR23","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1042\/bst021097s","volume":"21","author":"SM Cochrane","year":"1993","unstructured":"Cochrane SM, Furth AJ (1993) The role of bound lipid and transition metal in the formation of fluorescent advanced glycation endproducts by human serum albumin. Biochem Soc Trans 21(2):97S","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"777_CR24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.parkreldis.2009.02.013","volume":"15","author":"M D\u2019Amelio","year":"2009","unstructured":"D\u2019Amelio M, Ragonese P, Callari G, Di Benedetto N, Palmeri B, Terruso V, Salemi G, Famoso G, Aridon P, Savettieri G (2009) Diabetes preceding Parkinson\u2019s disease onset. A case\u2013control study. Parkinsonism Relat Disord 15(9):660\u2013664","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"777_CR25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","volume":"64","author":"E Dalfo","year":"2005","unstructured":"Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R, Ferrer I (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64(9):816\u2013830","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"777_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(01)02174-7","volume":"312","author":"W Deuther-Conrad","year":"2001","unstructured":"Deuther-Conrad W, Loske C, Schinzel R, Dringen R, Riederer P, M\u00fcnch G (2001) Advanced glycation endproducts change glutathione redox status in sh-sy5y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett 312(1):29\u201332","journal-title":"Neurosci Lett"},{"issue":"7","key":"777_CR27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI200318127","volume":"112","author":"X Du","year":"2003","unstructured":"Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M (2003) Inhibition of gapdh activity by poly(adp-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112(7):1049\u20131057","journal-title":"J Clin Invest"},{"issue":"1","key":"777_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1010052800347","volume":"2","author":"S Dukic-Stefanovic","year":"2001","unstructured":"Dukic-Stefanovic S, Schinzel R, Riederer P, M\u00fcnch G (2001) Ages in brain ageing: age-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology 2(1):19\u201334","journal-title":"Biogerontology"},{"issue":"1","key":"777_CR29","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1046\/j.1471-4159.2003.01988.x","volume":"87","author":"S Dukic-Stefanovic","year":"2003","unstructured":"Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, M\u00fcnch G (2003) Signal transduction pathways in mouse microglia n-11 cells activated by advanced glycation endproducts (ages). J Neurochem 87(1):2609\u20132615","journal-title":"J Neurochem"},{"issue":"12","key":"777_CR30","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/db09-0320","volume":"58","author":"B Duran-Jimenez","year":"2009","unstructured":"Duran-Jimenez B, Dobler D, Moffatt S, Rabbani N, Streuli CH, Thornalley PJ, Tomlinson DR, Gardiner NJ (2009) Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 58(12):2893\u20132903","journal-title":"Diabetes"},{"issue":"7","key":"777_CR31","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","volume":"101","author":"C Fiuza","year":"2003","unstructured":"Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF (2003) Inflammation-promoting activity of hmgb1 on human microvascular endothelial cells. Blood 101(7):2652\u20132660","journal-title":"Blood"},{"issue":"12","key":"777_CR32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0006-3223(91)90158-I","volume":"30","author":"Y Fujisawa","year":"1991","unstructured":"Fujisawa Y, Sasaki K, Akiyama K (1991) Increased insulin levels after ogtt load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 30(12):1219\u20131228","journal-title":"Biol Psychiatry"},{"issue":"6","key":"777_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s003910170018","volume":"34","author":"J Gasic-Milenkovic","year":"2001","unstructured":"Gasic-Milenkovic J, Loske C, Deuther-Conrad W, M\u00fcnch G (2001) Protein \u201cageing\u201d\u2014cytotoxicity of a glycated protein increases with its degree of age-modification. Z Gerontol Geriatr 34(6):457\u2013460","journal-title":"Z Gerontol Geriatr"},{"issue":"4","key":"777_CR34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1460-9568.2003.02506.x","volume":"17","author":"J Gasic-Milenkovic","year":"2003","unstructured":"Gasic-Milenkovic J, Dukic-Stefanovic S, Deuther-Conrad W, Gartner U, M\u00fcnch G (2003) Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and \u2018advanced glycation endproducts\u2019 in a murine microglia cell line. Eur J Neurosci 17(4):813\u2013821","journal-title":"Eur J Neurosci"},{"issue":"4","key":"777_CR35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/092986608784246515","volume":"15","author":"A Gasser","year":"2008","unstructured":"Gasser A, Forbes JM (2008) Advanced glycation: implications in tissue damage and disease. Protein Pept Lett 15(4):385\u2013391","journal-title":"Protein Pept Lett"},{"issue":"4","key":"777_CR36","first-page":"276","volume":"54","author":"A Gerdemann","year":"2000","unstructured":"Gerdemann A, Lemke HD, Nothdurft A, Heidland A, M\u00fcnch G, Bahner U, Schinzel R (2000) Low-molecular but not high-molecular advanced glycation end products (ages) are removed by high-flux dialysis. Clin Nephrol 54(4):276\u2013283","journal-title":"Clin Nephrol"},{"issue":"10","key":"777_CR37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2004.02.006","volume":"36","author":"X Girones","year":"2004","unstructured":"Girones X, Guimera A, Cruz-Sanchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sanchez FF (2004) N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer\u2019s disease. Free Radic Biol Med 36(10):1241\u20131247","journal-title":"Free Radic Biol Med"},{"issue":"41","key":"777_CR38","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1073\/pnas.0606887103","volume":"103","author":"JP Gnerer","year":"2006","unstructured":"Gnerer JP, Kreber RA, Ganetzky B (2006) Wasted away, a drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death. Proc Natl Acad Sci USA 103(41):14987\u201314993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"777_CR39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0165-0173(01)00055-8","volume":"35","author":"J Gotz","year":"2001","unstructured":"Gotz J (2001) Tau and transgenic animal models. Brain Res Brain Res Rev 35(3):266\u2013286","journal-title":"Brain Res Brain Res Rev"},{"issue":"11\u201312","key":"777_CR40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2006.01.004","volume":"1762","author":"F Gros-Louis","year":"2006","unstructured":"Gros-Louis F, Gaspar C, Rouleau GA (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta 1762(11\u201312):956\u2013972","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"777_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2443.2005.00817.x","volume":"10","author":"K Hamada","year":"2005","unstructured":"Hamada K, Kato M, Shimizu T, Ihara K, Mizuno T, Hakoshima T (2005) Crystal structure of the protein histidine phosphatase sixa in the multistep his-asp phosphorelay. Genes Cells 10(1):1\u201311","journal-title":"Genes Cells"},{"issue":"5","key":"777_CR42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2005-865600","volume":"113","author":"KM Haslbeck","year":"2005","unstructured":"Haslbeck KM, Schleicher E, Bierhaus A, Nawroth P, Haslbeck M, Neundorfer B, Heuss D (2005) The age\/rage\/nf-(kappa)b pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (igt). Exp Clin Endocrinol Diabetes 113(5):288\u2013291","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"777_CR43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1179\/174313206X152564","volume":"29","author":"KM Haslbeck","year":"2007","unstructured":"Haslbeck KM, Neundorfer B, Schlotzer-Schrehardtt U, Bierhaus A, Schleicher E, Pauli E, Haslbeck M, Hecht M, Nawroth P, Heuss D (2007) Activation of the rage pathway: a general mechanism in the pathogenesis of polyneuropathies? Neurol Res 29(1):103\u2013110","journal-title":"Neurol Res"},{"issue":"2","key":"777_CR44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-2007-11210","volume":"11","author":"AR Hipkiss","year":"2007","unstructured":"Hipkiss AR (2007) Could carnosine or related structures suppress Alzheimer\u2019s disease? J Alzheimers Dis 11(2):229\u2013240","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"777_CR45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/bbrc.1997.6944","volume":"236","author":"K Horie","year":"1997","unstructured":"Horie K, Miyata T, Yasuda T, Takeda A, Yasuda Y, Maeda K, Sobue G, Kurokawa K (1997) Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer\u2019s disease and aged neurons. Biochem Biophys Res Commun 236(2):327\u2013332","journal-title":"Biochem Biophys Res Commun"},{"issue":"4\u20135","key":"777_CR46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","volume":"105","author":"S Hoyer","year":"1998","unstructured":"Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105(4\u20135):415\u2013422","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"777_CR47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490(1\u20133):115\u2013125","journal-title":"Eur J Pharmacol"},{"key":"777_CR48","doi-asserted-by":"crossref","unstructured":"Huijberts MS, Schaper NC, Schalkwijk CG (2008) Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev 24(Suppl 1):S19\u2013S24","DOI":"10.1002\/dmrr.861"},{"issue":"2","key":"777_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0404.2008.01133.x","volume":"120","author":"J Ilzecka","year":"2009","unstructured":"Ilzecka J (2009) Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 120(2):119\u2013122","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"777_CR50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2004.07.026","volume":"321","author":"H Iwata","year":"2004","unstructured":"Iwata H, Ukeda H, Maruyama T, Fujino T, Sawamura M (2004) Effect of carbonyl compounds on red blood cells deformability. Biochem Biophys Res Commun 321(3):700\u2013706","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"777_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2003.08.017","volume":"419","author":"G Jerums","year":"2003","unstructured":"Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M (2003) Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 419(1):55\u201362","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"777_CR52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrfmmm.2005.03.024","volume":"579","author":"M Kalousova","year":"2005","unstructured":"Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J (2005) Advanced glycoxidation end products in chronic diseases\u2014clinical chemistry and genetic background. Mutat Res 579(1\u20132):37\u201346","journal-title":"Mutat Res"},{"issue":"3","key":"777_CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14660820050515160","volume":"1","author":"S Kato","year":"2000","unstructured":"Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, Kusaka H, Shibata N, Kato M, Nakano I, Ohama E (2000) New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (sod1) gene mutations: inclusions containing sod1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord 1(3):163\u2013184","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"2","key":"777_CR54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/146608202760196020","volume":"3","author":"S Kikuchi","year":"2002","unstructured":"Kikuchi S, Shinpo K, Ogata A, Tsuji S, Takeuchi M, Makita Z, Tashiro K (2002) Detection of n epsilon-(carboxymethyl)lysine (cml) and non-cml advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotroph Lateral Scler Other Motor Neuron Disord 3(2):63\u201368","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"2\u20133","key":"777_CR55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0165-0173(02)00273-4","volume":"41","author":"S Kikuchi","year":"2003","unstructured":"Kikuchi S, Shinpo K, Takeuchi M, Yamagishi S, Makita Z, Sasaki N, Tashiro K (2003) Glycation\u2014a sweet tempter for neuronal death. Brain Res Brain Res Rev 41(2\u20133):306\u2013323","journal-title":"Brain Res Brain Res Rev"},{"issue":"6","key":"777_CR56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00001756-199504190-00010","volume":"6","author":"T Kimura","year":"1995","unstructured":"Kimura T, Takamatsu J, Araki N, Goto M, Kondo A, Miyakawa T, Horiuchi S (1995) Are advanced glycation end-products associated with amyloidosis in Alzheimer\u2019s disease? Neuroreport 6(6):866\u2013868","journal-title":"Neuroreport"},{"issue":"6","key":"777_CR57","first-page":"400","volume":"54","author":"RH King","year":"2001","unstructured":"King RH (2001) The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 54(6):400\u2013408","journal-title":"Mol Pathol"},{"issue":"2","key":"777_CR58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(99)01415-8","volume":"830","author":"LW Ko","year":"1999","unstructured":"Ko LW, Ko EC, Nacharaju P, Liu WK, Chang E, Kenessey A, Yen SH (1999) An immunochemical study on tau glycation in paired helical filaments. Brain Res 830(2):301\u2013313","journal-title":"Brain Res"},{"issue":"4","key":"777_CR59","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","volume":"29","author":"CT Kodl","year":"2008","unstructured":"Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29(4):494\u2013511","journal-title":"Endocr Rev"},{"key":"777_CR60","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.exger.2010.03.001","volume":"45","author":"M Krautwald","year":"2010","unstructured":"Krautwald M, M\u00fcnch G (2010) Advanced glycation end products as biomarkers and gerontotoxins\u2014a basis to explore methylglyoxal-lowering agents for Alzheimer\u2019s disease? Exp Gerontol 45:744\u2013751","journal-title":"Exp Gerontol"},{"issue":"3","key":"777_CR61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00702-003-0038-2","volume":"111","author":"B Kuhla","year":"2004","unstructured":"Kuhla B, Loske C, Garcia De Arriba S, Schinzel R, Huber J, M\u00fcnch G (2004) Differential effects of \u201cadvanced glycation endproducts\u201d and beta-amyloid peptide on glucose utilization and atp levels in the neuronal cell line sh-sy5y. J Neural Transm 111(3):427\u2013439","journal-title":"J Neural Transm"},{"issue":"5","key":"777_CR62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000116835","volume":"32","author":"H Langemann","year":"1992","unstructured":"Langemann H, Kabiersch A, Newcombe J (1992) Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol 32(5):248\u2013252","journal-title":"Eur Neurol"},{"issue":"34","key":"777_CR63","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","volume":"269","author":"MD Ledesma","year":"1994","unstructured":"Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269(34):21614\u201321619","journal-title":"J Biol Chem"},{"issue":"8\u20139","key":"777_CR64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s007020050108","volume":"105","author":"C Loske","year":"1998","unstructured":"Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, M\u00fcnch G (1998) Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105(8\u20139):1005\u20131015","journal-title":"J Neural Transm"},{"issue":"13","key":"777_CR65","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1046\/j.1432-1327.2000.01452.x","volume":"267","author":"C Loske","year":"2000","unstructured":"Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, M\u00fcnch G (2000) Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem 267(13):4171\u20134178","journal-title":"Eur J Biochem"},{"key":"777_CR66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1433.059","volume":"1126","author":"IK Lukic","year":"2008","unstructured":"Lukic IK, Humpert PM, Nawroth PP, Bierhaus A (2008) The rage pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann N Y Acad Sci 1126:76\u201380","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"777_CR67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cercor\/bhh123","volume":"15","author":"HJ L\u00fcth","year":"2005","unstructured":"L\u00fcth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, M\u00fcnch G (2005) Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer\u2019s disease brains. Cereb Cortex 15(2):211\u2013220","journal-title":"Cereb Cortex"},{"issue":"7","key":"777_CR68","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1074\/jbc.272.7.4037","volume":"272","author":"S Miyata","year":"1997","unstructured":"Miyata S, Liu BF, Shoda H, Ohara T, Yamada H, Suzuki K, Kasuga M (1997) Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes. J Biol Chem 272(7):4037\u20134042","journal-title":"J Biol Chem"},{"issue":"4481","key":"777_CR69","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.6779377","volume":"211","author":"VM Monnier","year":"1981","unstructured":"Monnier VM, Cerami A (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211(4481):491\u2013493","journal-title":"Science"},{"issue":"3","key":"777_CR70","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-291X(05)80875-7","volume":"173","author":"CJ Mullarkey","year":"1990","unstructured":"Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173(3):932\u2013939","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"777_CR71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02260940","volume":"8","author":"G M\u00fcnch","year":"1994","unstructured":"M\u00fcnch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P (1994) The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect 8(3):193\u2013208","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"1","key":"777_CR72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4439(96)00062-2","volume":"1360","author":"G M\u00fcnch","year":"1997","unstructured":"M\u00fcnch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Muller R, Neumann A, Schinzel R, Cunningham AM (1997a) Influence of advanced glycation end-products and age-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta 1360(1):17\u201329","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"777_CR73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-0173(96)00016-1","volume":"23","author":"G M\u00fcnch","year":"1997","unstructured":"M\u00fcnch G, Thome J, Foley P, Schinzel R, Riederer P (1997b) Advanced glycation endproducts in ageing and Alzheimer\u2019s disease. Brain Res Brain Res Rev 23(1\u20132):134\u2013143","journal-title":"Brain Res Brain Res Rev"},{"issue":"4\u20135","key":"777_CR74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s007020050069","volume":"105","author":"G M\u00fcnch","year":"1998","unstructured":"M\u00fcnch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P (1998) Alzheimer\u2019s disease\u2013synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105(4\u20135):439\u2013461","journal-title":"J Neural Transm"},{"issue":"10","key":"777_CR75","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/13704","volume":"17","author":"G M\u00fcnch","year":"1999","unstructured":"M\u00fcnch G, Schicktanz D, Behme A, Gerlach M, Riederer P, Palm D, Schinzel R (1999) Amino acid specificity of glycation and protein-age crosslinking reactivities determined with a dipeptide spot library. Nat Biotechnol 17(10):1006\u20131010","journal-title":"Nat Biotechnol"},{"issue":"3\u20134","key":"777_CR76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","volume":"20","author":"G M\u00fcnch","year":"2000","unstructured":"M\u00fcnch G, L\u00fcth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20(3\u20134):253\u2013257","journal-title":"J Chem Neuroanat"},{"key":"777_CR77","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mnfr.200600254","volume":"51","author":"S Muscat","year":"2007","unstructured":"Muscat S, Pelka J, Hegele J, Weigle B, M\u00fcnch G, Pischetsrieder M (2007) Coffee and maillard products activate nf-kappab in macrophages via h(2)o(2) production. Mol Nutr Food Res 51:525\u2013535","journal-title":"Mol Nutr Food Res"},{"key":"777_CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0074-7742(02)50071-4","volume":"50","author":"IG Obrosova","year":"2002","unstructured":"Obrosova IG (2002) How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol 50:3\u201335","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"777_CR79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11892-003-0005-1","volume":"3","author":"IG Obrosova","year":"2003","unstructured":"Obrosova IG (2003) Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 3(6):439\u2013445","journal-title":"Curr Diab Rep"},{"issue":"10","key":"777_CR80","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbadis.2008.11.005","volume":"1792","author":"IG Obrosova","year":"2009","unstructured":"Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792(10):931\u2013940","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"777_CR81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","volume":"53","author":"IG Obrosova","year":"2004","unstructured":"Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJ (2004) Role of poly(adp-ribose) polymerase activation in diabetic neuropathy. Diabetes 53(3):711\u2013720","journal-title":"Diabetes"},{"issue":"2","key":"777_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1042\/bst0300030","volume":"30","author":"J Olah","year":"2002","unstructured":"Olah J, Orosz F, Keseru GM, Kovari Z, Kovacs J, Hollan S, Ovadi J (2002) Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease. Biochem Soc Trans 30(2):30\u201338","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"777_CR83","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood.V98.10.3106","volume":"98","author":"F Orosz","year":"2001","unstructured":"Orosz F, Olah J, Alvarez M, Keseru GM, Szabo B, Wagner G, Kovari Z, Horanyi M, Baroti K, Martial JA, Hollan S, Ovadi J (2001) Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency. Blood 98(10):3106\u20133112","journal-title":"Blood"},{"issue":"1","key":"777_CR84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/bbrc.1998.8401","volume":"245","author":"BJ Ortwerth","year":"1998","unstructured":"Ortwerth BJ, James H, Simpson G, Linetsky M (1998) The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones. Biochem Biophys Res Commun 245(1):161\u2013165","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"777_CR85","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the rotterdam study. Neurology 53(9):1937\u20131942","journal-title":"Neurology"},{"issue":"3","key":"777_CR86","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867053363207","volume":"12","author":"P Pacher","year":"2005","unstructured":"Pacher P, Obrosova IG, Mabley JG, Szabo C (2005) Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12(3):267\u2013275","journal-title":"Curr Med Chem"},{"issue":"9","key":"777_CR87","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7(9):710\u2013723","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"777_CR88","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1524-475X.2009.00518.x","volume":"17","author":"M Peppa","year":"2009","unstructured":"Peppa M, Stavroulakis P, Raptis SA (2009) Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen 17(4):461\u2013472","journal-title":"Wound Repair Regen"},{"issue":"Pt 5","key":"777_CR89","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1042\/BST0361045","volume":"36","author":"N Rabbani","year":"2008","unstructured":"Rabbani N, Thornalley PJ (2008) Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 36(Pt 5):1045\u20131050","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"777_CR90","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00125-008-1224-4","volume":"52","author":"N Rabbani","year":"2009","unstructured":"Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, Thornalley PJ (2009) High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52(2):208\u2013212","journal-title":"Diabetologia"},{"key":"777_CR91","doi-asserted-by":"crossref","unstructured":"Reddy VP, Garrett MR, Perry G, Smith MA (2005) Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ 18:pe12","DOI":"10.1126\/sageke.2005.18.pe12"},{"issue":"15","key":"777_CR92","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1096\/fj.04-1900com","volume":"18","author":"LL Rong","year":"2004","unstructured":"Rong LL, Yan SF, Wendt T, Hans D, Pachydaki S, Bucciarelli LG, Adebayo A, Qu W, Lu Y, Kostov K, Lalla E, Yan SD, Gooch C, Szabolcs M, Trojaborg W, Hays AP, Schmidt AM (2004) Rage modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J 18(15):1818\u20131825","journal-title":"FASEB J"},{"issue":"5\u20136","key":"777_CR93","first-page":"355","volume":"23","author":"LL Rong","year":"2005","unstructured":"Rong LL, Gooch C, Szabolcs M, Herold KC, Lalla E, Hays AP, Yan SF, Yan SS, Schmidt AM (2005) Rage: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair. Restor Neurol Neurosci 23(5\u20136):355\u2013365","journal-title":"Restor Neurol Neurosci"},{"issue":"6","key":"777_CR94","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncpneuro0504","volume":"3","author":"G Said","year":"2007","unstructured":"Said G (2007) Diabetic neuropathy\u2014a review. Nat Clin Pract Neurol 3(6):331\u2013340","journal-title":"Nat Clin Pract Neurol"},{"issue":"7","key":"777_CR95","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200317115","volume":"111","author":"T Sakaguchi","year":"2003","unstructured":"Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y (2003) Central role of rage-dependent neointimal expansion in arterial restenosis. J Clin Invest 111(7):959\u2013972","journal-title":"J Clin Invest"},{"key":"777_CR96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","volume":"72","author":"M Salkovic-Petrisic","year":"2007","unstructured":"Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 72:217\u2013233","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"777_CR97","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","volume":"153","author":"N Sasaki","year":"1998","unstructured":"Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z (1998) Advanced glycation end products in Alzheimer\u2019s disease and other neurodegenerative diseases. Am J Pathol 153(4):1149\u20131155","journal-title":"Am J Pathol"},{"issue":"2","key":"777_CR98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(02)00310-5","volume":"326","author":"N Sasaki","year":"2002","unstructured":"Sasaki N, Takeuchi M, Chowei H, Kikuchi S, Hayashi Y, Nakano N, Ikeda H, Yamagishi S, Kitamoto T, Saito T, Makita Z (2002) Advanced glycation end products (age) and their receptor (rage) in the brain of patients with creutzfeldt-jakob disease with prion plaques. Neurosci Lett 326(2):117\u2013120","journal-title":"Neurosci Lett"},{"issue":"1","key":"777_CR99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/beha.2000.0061","volume":"13","author":"AS Schneider","year":"2000","unstructured":"Schneider AS (2000) Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillieres Best Pract Res Clin Haematol 13(1):119\u2013140","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"issue":"7","key":"777_CR100","first-page":"1051","volume":"44","author":"K Sebekova","year":"1998","unstructured":"Sebekova K, Schinzel R, Ling Simm HA, Xiang G, Gekle M, M\u00fcnch G, Vamvakas S, Heidland A (1998) Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line llc-pk1. Cell Mol Biol (Noisy-le-grand) 44(7):1051\u20131060","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"3","key":"777_CR101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s004010050980","volume":"97","author":"N Shibata","year":"1999","unstructured":"Shibata N, Hirano A, Kato S, Nagai R, Horiuchi S, Komori T, Umahara T, Asayama K, Kobayashi M (1999) Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol (Berl) 97(3):240\u2013246","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"777_CR102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-002-0537-5","volume":"104","author":"N Shibata","year":"2002","unstructured":"Shibata N, Hirano A, Hedley-Whyte ET, Dal Canto MC, Nagai R, Uchida K, Horiuchi S, Kawaguchi M, Yamamoto T, Kobayashi M (2002a) Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol (Berl) 104(2):171\u2013178","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"777_CR103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1440-1789.2002.00449.x","volume":"22","author":"N Shibata","year":"2002","unstructured":"Shibata N, Oda H, Hirano A, Kato Y, Kawaguchi M, Dal Canto MC, Uchida K, Sawada T, Kobayashi M (2002b) Molecular biological approaches to neurological disorders including knockout and transgenic mouse models. Neuropathology 22(4):337\u2013349","journal-title":"Neuropathology"},{"issue":"3","key":"777_CR104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36(3):348\u2013355","journal-title":"Ann Neurol"},{"issue":"4","key":"777_CR105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0306-9877(94)90132-5","volume":"42","author":"MA Smith","year":"1994","unstructured":"Smith MA, Perry G (1994) Alzheimer disease: an imbalance of proteolytic regulation? Med Hypotheses 42(4):277\u2013279","journal-title":"Med Hypotheses"},{"issue":"12","key":"777_CR106","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","volume":"91","author":"MA Smith","year":"1994","unstructured":"Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91(12):5710\u20135714","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"777_CR107","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/00001756-199508000-00001","volume":"6","author":"MA Smith","year":"1995","unstructured":"Smith MA, Monnier VM, Sayre LM, Perry G (1995) Amyloidosis, advanced glycation end products and Alzheimer disease. Neuroreport 6(12):1595\u20131596","journal-title":"Neuroreport"},{"issue":"2","key":"777_CR108","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00403972","volume":"39","author":"MA Smith","year":"1996","unstructured":"Smith MA, Sayre LM, Perry G (1996a) Diabetes mellitus and Alzheimer\u2019s disease: glycation as a biochemical link. Diabetologia 39(2):247","journal-title":"Diabetologia"},{"issue":"2\u20133","key":"777_CR109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0304-3940(96)13100-1","volume":"217","author":"MA Smith","year":"1996","unstructured":"Smith MA, Tabaton M, Perry G (1996b) Early contribution of oxidative glycation in Alzheimer disease. Neurosci Lett 217(2\u20133):210\u2013211","journal-title":"Neurosci Lett"},{"key":"777_CR110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2377-7-35","volume":"7","author":"L Southern","year":"2007","unstructured":"Southern L, Williams J, Esiri MM (2007) Immunohistochemical study of n-epsilon-carboxymethyl lysine (cml) in human brain: relation to vascular dementia. BMC Neurol 7:35","journal-title":"BMC Neurol"},{"key":"777_CR111","first-page":"809","volume":"247","author":"V Srikanth","year":"2009","unstructured":"Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, M\u00fcnch G (2009) Advanced glycation endproducts and their receptor rage in Alzheimer\u2019s disease. Neurobiol Aging 247:809\u2013814","journal-title":"Neurobiol Aging"},{"issue":"6","key":"777_CR112","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/1352458507088105","volume":"14","author":"Z Sternberg","year":"2008","unstructured":"Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F (2008) Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity. Mult Scler 14(6):759\u2013763","journal-title":"Mult Scler"},{"issue":"6","key":"777_CR113","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.freeradbiomed.2005.10.061","volume":"40","author":"A Stolzing","year":"2006","unstructured":"Stolzing A, Widmer R, Jung T, Voss P, Grune T (2006) Degradation of glycated bovine serum albumin in microglial cells. Free Radic Biol Med 40(6):1017\u20131027","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"777_CR114","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138161208784139774","volume":"14","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Yasujima M, Yagihashi S (2008) Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 14(10):953\u2013961","journal-title":"Curr Pharm Des"},{"issue":"8","key":"777_CR115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1096\/fj.02-0768fje","volume":"17","author":"R Takamiya","year":"2003","unstructured":"Takamiya R, Takahashi M, Myint T, Park YS, Miyazawa N, Endo T, Fujiwara N, Sakiyama H, Misonou Y, Miyamoto Y, Fujii J, Taniguchi N (2003) Glycation proceeds faster in mutated cu, zn-superoxide dismutases related to familial amyotrophic lateral sclerosis. FASEB J 17(8):938\u2013940","journal-title":"FASEB J"},{"issue":"1","key":"777_CR116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(96)13275-4","volume":"221","author":"A Takedo","year":"1996","unstructured":"Takedo A, Yasuda T, Miyata T, Mizuno K, Li M, Yoneyama S, Horie K, Maeda K, Sobue G (1996) Immunohistochemical study of advanced glycation end products in aging and Alzheimer\u2019s disease brain. Neurosci Lett 221(1):17\u201320","journal-title":"Neurosci Lett"},{"issue":"11","key":"777_CR117","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s001150050073","volume":"67","author":"J Thome","year":"1996","unstructured":"Thome J, Kornhuber J, M\u00fcnch G, Schinzel R, Taneli Y, Zielke B, Rosler M, Riederer P (1996) [new hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (ages)]. Nervenarzt 67(11):924\u2013929","journal-title":"Nervenarzt"},{"issue":"3","key":"777_CR118","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj2540751","volume":"254","author":"PJ Thornalley","year":"1988","unstructured":"Thornalley PJ (1988) Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 254(3):751\u2013755","journal-title":"Biochem J"},{"key":"777_CR119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0074-7742(02)50072-6","volume":"50","author":"PJ Thornalley","year":"2002","unstructured":"Thornalley PJ (2002) Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 50:37\u201357","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"777_CR120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157339905774574383","volume":"1","author":"PJ Thornalley","year":"2005","unstructured":"Thornalley PJ (2005) The potential role of thiamine (vitamin b1) in diabetic complications. Curr Diabetes Rev 1(3):287\u2013298","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"777_CR121","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002512-199609020-00001","volume":"9","author":"SR Thorpe","year":"1996","unstructured":"Thorpe SR, Baynes JW (1996) Role of the maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9(2):69\u201377","journal-title":"Drugs Aging"},{"issue":"8","key":"777_CR122","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/156652407783220705","volume":"7","author":"C Toth","year":"2007","unstructured":"Toth C, Martinez J, Zochodne DW (2007a) Rage, diabetes, and the nervous system. Curr Mol Med 7(8):766\u2013776","journal-title":"Curr Mol Med"},{"key":"777_CR123","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/db07-0339","volume":"57","author":"C Toth","year":"2007","unstructured":"Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW (2007b) Rage and experimental diabetic neuropathy. Diabetes 57:1002\u20131017","journal-title":"Diabetes"},{"issue":"4","key":"777_CR124","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/db07-0339","volume":"57","author":"C Toth","year":"2008","unstructured":"Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J, Nguyen MD, Schmidt AM, Zochodne DW (2008) Receptor for advanced glycation end products (rages) and experimental diabetic neuropathy. Diabetes 57(4):1002\u20131017","journal-title":"Diabetes"},{"issue":"4","key":"777_CR125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1900\/RDS.2009.6.230","volume":"6","author":"N Vallianou","year":"2009","unstructured":"Vallianou N, Evangelopoulos A, Koutalas P (2009) Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud 6(4):230\u2013236","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"777_CR126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.2682","volume":"221","author":"H Vicente Miranda","year":"2010","unstructured":"Vicente Miranda H, Outeiro TF (2010) The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 221(1):13\u201325","journal-title":"J Pathol"},{"issue":"2","key":"777_CR127","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2006-0073","volume":"148","author":"AM Vincent","year":"2007","unstructured":"Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, Feldman EL (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148(2):548\u2013558","journal-title":"Endocrinology"},{"issue":"5","key":"777_CR128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncpendmet0142","volume":"2","author":"A Vinik","year":"2006","unstructured":"Vinik A, Ullal J, Parson HK, Casellini CM (2006) Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2(5):269\u2013281","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"11","key":"777_CR129","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","volume":"91","author":"MP Vitek","year":"1994","unstructured":"Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91(11):4766\u20134770","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"777_CR130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03033780","volume":"7","author":"J Webster","year":"2005","unstructured":"Webster J, Urban C, Berbaum K, Loske C, Alpar A, Gartner U, de Arriba SG, Arendt T, M\u00fcnch G (2005) The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res 7(1\u20132):95\u2013101","journal-title":"Neurotox Res"},{"issue":"2","key":"777_CR131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0887-8994(03)00423-5","volume":"30","author":"JM Wilmshurst","year":"2004","unstructured":"Wilmshurst JM, Wise GA, Pollard JD, Ouvrier RA (2004) Chronic axonal neuropathy with triosephosphate isomerase deficiency. Pediatr Neurol 30(2):146\u2013148","journal-title":"Pediatr Neurol"},{"key":"777_CR132","first-page":"259","volume":"304","author":"SP Wolff","year":"1989","unstructured":"Wolff SP, Bascal ZA, Hunt JV (1989) \u201cAutoxidative glycosylation\u201d: free radicals and glycation theory. Prog Clin Biol Res 304:259\u2013275","journal-title":"Prog Clin Biol Res"},{"issue":"1\u20132","key":"777_CR133","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(01)02872-4","volume":"920","author":"A Wong","year":"2001","unstructured":"Wong A, L\u00fcth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, M\u00fcnch G (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer\u2019s disease. Brain Res 920(1\u20132):32\u201340","journal-title":"Brain Res"},{"issue":"2","key":"777_CR134","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","volume":"394","author":"S Wu","year":"2006","unstructured":"Wu S, Ren J (2006) Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and tnf-alpha. Neurosci Lett 394(2):158\u2013162","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"777_CR135","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.diabres.2007.01.054","volume":"77","author":"S Yagihashi","year":"2007","unstructured":"Yagihashi S, Yamagishi S, Wada R (2007) Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract 77(Suppl 1):S184\u2013S189","journal-title":"Diabetes Res Clin Pract"},{"issue":"16","key":"777_CR136","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","volume":"91","author":"SD Yan","year":"1994","unstructured":"Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith MA et al (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91(16):7787\u20137791","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-010-0777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-010-0777-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-010-0777-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T21:02:33Z","timestamp":1636664553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-010-0777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":136,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s00726-010-0777-y","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}